US Patent Family Members and Approved Drugs for European Patent Office Patent: 2076541
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: EP2076541
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 7,767,206 | 2044-05-16 | brodalumab | Valeant Pharmaceuticals Luxembourg S.à.r.l. | SILIQ |
| 7,786,284 | 2044-05-16 | brodalumab | Valeant Pharmaceuticals Luxembourg S.à.r.l. | SILIQ |
| 7,833,527 | 2044-05-16 | brodalumab | Valeant Pharmaceuticals Luxembourg S.à.r.l. | SILIQ |
| 7,939,070 | 2044-05-16 | brodalumab | Valeant Pharmaceuticals Luxembourg S.à.r.l. | SILIQ |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
